Bolt Toki, Tufman Amanda, Sellmer Laura, Kahnert Kathrin, Mertsch Pontus, Kovács Julia, Kauffmann-Guerrero Diego, Munker Dieter, Manapov Farkhad, Schneider Christian, Behr Juergen, Walter Julia
Department of Medicine V, University Hospital, LMU Munich, München, Germany.
Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), München, Germany.
Clin Med Insights Oncol. 2022 Sep 27;16:11795549221123618. doi: 10.1177/11795549221123618. eCollection 2022.
The COVID-19 vaccines, face masks, and social distancing are effective interventions to prevent SARS-CoV-2 infections. In this study, we aimed to determine lung cancer patients' attitudes toward vaccination, changes in behavior after vaccination, and willingness to continue mask wearing after the pandemic.
We sent out questionnaires to 220 thoracic oncology patients treated at our lung cancer center in May 2021. The questionnaire focused on patients' vaccination status, self-reported experiences surrounding vaccination, and assessed changes in behaviors before and after vaccination as well as opinions toward mask wearing after the pandemic. Results are presented as absolute and relative frequencies and means with standard deviation and compared using test, paired test, and analysis of variance test as well as chi test, and Fisher exact text.
About 91.0% of patients reported having received at least 1 vaccination. About 73.3% of patients reported having at least 1 reaction to the vaccination. The most common reactions were pain at the injection site, fatigue, and headache. After vaccination, patients increased contact with family and friends, use of public transport, and grocery shopping. Overall, the level of willingness to wear masks beyond the end of the pandemic differed according to vaccination status.
Acceptance of the COVID-19 vaccination among thoracic oncology patients in Germany was high. Overall, patients with thoracic malignancies tolerated the COVID-19 vaccination well. Rate of adverse reaction was not higher compared with the general population. After the vaccination, patients increased social contacts and usage of public transport. These changes suggest positive psychological effects on quality of life. While reducing social distancing can increase the risk of infection, our results indicate that an extension of mask mandates after the pandemic would likely be accepted by a majority of thoracic oncology patients, suggesting that our cohort was still aware and in support of other measure of protection.
新冠病毒疾病(COVID-19)疫苗、口罩和社交距离是预防严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的有效干预措施。在本研究中,我们旨在确定肺癌患者对疫苗接种的态度、接种疫苗后的行为变化以及在疫情大流行后继续佩戴口罩的意愿。
2021年5月,我们向在我们肺癌中心接受治疗的220名胸科肿瘤患者发放了问卷。问卷聚焦于患者的疫苗接种状况、自我报告的疫苗接种相关经历,并评估了接种疫苗前后的行为变化以及对疫情大流行后佩戴口罩的看法。结果以绝对频率和相对频率以及均值和标准差表示,并使用t检验、配对t检验、方差分析以及卡方检验和Fisher精确检验进行比较。
约91.0%的患者报告至少接种了1剂疫苗。约73.3%的患者报告至少出现了1种疫苗接种反应。最常见的反应是注射部位疼痛、疲劳和头痛。接种疫苗后,患者增加了与家人和朋友的接触、公共交通的使用以及杂货店购物。总体而言,疫情大流行结束后佩戴口罩的意愿程度因疫苗接种状况而异。
德国胸科肿瘤患者对新冠病毒疾病(COVID-19)疫苗的接受度很高。总体而言,胸科恶性肿瘤患者对新冠病毒疾病(COVID-19)疫苗耐受性良好。不良反应发生率与普通人群相比并不更高。接种疫苗后,患者增加了社交接触和公共交通的使用。这些变化表明对生活质量有积极的心理影响。虽然减少社交距离会增加感染风险,但我们的结果表明,疫情大流行后延长强制佩戴口罩的要求很可能会被大多数胸科肿瘤患者接受,这表明我们的研究队列仍然意识到并支持其他防护措施。